Showing results (171-180 of 223) with videos related to
Sort By:
Pageof 23
The Lancet. HIV|May 10, 2019
Co-formulated bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir with emtricitabine and tenofovir alafenamide for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trialHans-Jürgen Stellbrink, José R Arribas, Jeffrey L Stephens, et al.International Journal of Antimicrobial Agents|February 16, 2019
Prevalence of predicted resistance to doravirine in HIV-1-positive patients after exposure to non-nucleoside reverse transcriptase inhibitorsGaetana Sterrantino, Vanni Borghi, Anna Paola Callegaro, et al.BMC Infectious Diseases|March 17, 2017
Role of systemic inflammation scores for prediction of clinical outcomes in patients treated with atazanavir not boosted by ritonavir in the Italian MASTER cohortMaria Concetta Postorino, Mattia Prosperi, Emanuele Focà, et al.The Journal of Antimicrobial Chemotherapy|July 22, 2009
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weightingMaurizio Zazzi, Mattia Prosperi, Ilaria Vicenti, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 24, 2019
Impact of diabetes on the risk of serious liver events and liver-related deaths in people living with HIV and hepatitis C co-infection: data from the ICONA Foundation Cohort StudySebastiano Leone, Patrizia Lorenzini, Alessandro Cozzi-Lepri, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 26, 2020
Marked decrease in acquired resistance to antiretrovirals in latest years in ItalyAlessia Lai, Marco Franzetti, Annalisa Bergna, et al.Journal of Clinical Medicine|January 21, 2022
Correlates of Treatment and Disease Burden in People Living with HIV (PLHIV) in ItalyAntonella Cingolani, Alessandro Tavelli, Franco Maggiolo, et al.International Journal of Antimicrobial Agents|July 12, 2022
Impact of pre-existent drug resistance on virological efficacy of single-tablet regimens in people living with HIVGiulia Stella, Lorenzo Volpicelli, Domenico Di Carlo, et al.AIDS (London, England)|February 13, 2024
Switch to bictegravir/emtricitabine/tenofovir alafenamide from dolutegravir-based therapyChloe Orkin, Andrea Antinori, Jürgen K Rockstroh, et al.BMC Public Health|April 18, 2015
Cancer incidence and mortality for all causes in HIV-infected patients over a quarter century: a multicentre cohort studyElena Raffetti, Laura Albini, Daria Gotti, et al.Pageof 23